FDA Inspection
Opada Alzohaili, M.D.Opada Alzohaili, M.D. – FDA Inspection, Mar 29, 2016
Record Details
This FDA Inspection record concerns Opada Alzohaili, M.D., with an inspection on March 29, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Opada Alzohaili, M.D.
- Inspection Date
- March 29, 2016
- Product Type
- Drugs
View Company Profile
ID · 15a25c00-f3be-467d-93f2-e5efa681b613
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 968583
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Opada Alzohaili, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 29, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 14, 2013 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Opada Alzohaili, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.